Ads
related to: dupixent dosing- Getting Started
Instructions For Use
Watch The Video Today!
- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Injection Support Center
Get Help With Taking DUPIXENT®
View Injection Resources Now
- Pricing And Insurance
Check Copay Eligibility
Learn About Payment Options
- Getting Started
Search results
Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study
Zacks via Yahoo Finance· 4 months agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced positive study data on the...
Sanofi (SNY) Dupixent Esophagitis Kids Study Meets Goal
Zacks via Yahoo Finance· 2 years agoSanofi's (SNY) Dupixent shows the potential to improve signs of eosinophilic esophagitis in a phase...
Regeneron-Sanofi's Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years
Benzinga via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) Phase 3 trial of Dupixent...
Regeneron (REGN), Sanofi's Dupixent Gets Label Update in US
Zacks via Yahoo Finance· 2 months agoThe FDA updates Regeneron (REGN) and Sanofi's Dupixent label in the United States to include...
Pharma Stock Roundup: MRK Buys Cancer Drug Rights, SNY Dupixent Kids Study Succeeds
Zacks via Yahoo Finance· 2 years agoThis week, Merck MRK in-licensed co-development rights to Orion Corporation’s prostate cancer...
Regeneron (REGN), Sanofi Get Priority Review for Dupixent sBLA
Zacks via Yahoo Finance· 2 years agoThe FDA accepts and grants priority review to Regeneron (REGN) and Sanofi's sBLA for Dupixent to...
Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2...
Benzinga via Yahoo Finance· 2 years agoThe European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) for...
Regeneron (REGN) Q3 Earnings & Sales Beat on Eylea, Dupixent
Zacks via Yahoo Finance· 1 year agoRegeneron (REGN) tops earnings and sales estimates for the third quarter, driven by its lead drug...
Regeneron Jumps On Third-Quarter Beat As High-Dose Eylea Delivers
Investor's Business Daily· 5 months agoRegeneron Pharmaceuticals' high-dose Eylea is off to a strong start in the U.S., the company said...
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
Zacks via Yahoo Finance· 1 year agoThis week, Sanofi SNY and partner Regeneron’s REGN blockbuster medicine, Dupixent succeeded in a...
Ads
related to: dupixent dosing